Haemolytic disease of the fetus and newborn (HDFN) occurs when there is transplacental passage of maternal immunoglobulin G ...

James Harrison’s legacy is at the heart of a wild story about canny science, boundless goodwill and an errant blood transfusion vanquishing a devastating and deadly disease.

Without it, babies may develop hemolytic disease of the fetus and newborn (HDFN), a blood disorder that can be fatal. Despite an aversion to needles, Harrison began donating in 1954 at age 18 ...

The FDA bestows a Fast Track designation to Johnson & Johnson's nipocalimab for treating moderate-to-severe Sjogren's disease ...

While it is impossible to know how many babies would have died without Anti-D protection, HDFN affected as many as 1 in 100 women until 1966, government data shows. Following the success of a 1966 ...

While it is impossible to know how many babies would have died without Anti-D protection, HDFN affected as many as 1 in 100 women until 1966, government data shows. Following the success of a 1966 ...

Before anti-D was discovered, HDFN killed more infants than almost any other disease and caused lifelong disability. Up to one in six newborns were at risk, amounting to 40,000 babies every year ...

James Harrison's blood contained a rare antibody, which has been instrumental in protecting unborn babies from haemolytic disease of the foetus and newborn.